SI2600846T1 - Farmacevtska odmerna oblika, ki obsega 6'-fluoro-(N-metil- ali N,N-dimetil-)-4-fenil-4',9'-dihidro-3'H-spiro(cikloheksan-1,1'-pirano (3,4,b)indol)-4-amin - Google Patents
Farmacevtska odmerna oblika, ki obsega 6'-fluoro-(N-metil- ali N,N-dimetil-)-4-fenil-4',9'-dihidro-3'H-spiro(cikloheksan-1,1'-pirano (3,4,b)indol)-4-aminInfo
- Publication number
- SI2600846T1 SI2600846T1 SI201130711T SI201130711T SI2600846T1 SI 2600846 T1 SI2600846 T1 SI 2600846T1 SI 201130711 T SI201130711 T SI 201130711T SI 201130711 T SI201130711 T SI 201130711T SI 2600846 T1 SI2600846 T1 SI 2600846T1
- Authority
- SI
- Slovenia
- Prior art keywords
- cylohexane
- pyrano
- indol
- spiro
- dihydro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37064810P | 2010-08-04 | 2010-08-04 | |
EP10008117 | 2010-08-04 | ||
EP11745928.9A EP2600846B1 (en) | 2010-08-04 | 2011-08-04 | Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
PCT/EP2011/003900 WO2012016695A2 (en) | 2010-08-04 | 2011-08-04 | Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2600846T1 true SI2600846T1 (sl) | 2016-02-29 |
Family
ID=43382487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201130711T SI2600846T1 (sl) | 2010-08-04 | 2011-08-04 | Farmacevtska odmerna oblika, ki obsega 6'-fluoro-(N-metil- ali N,N-dimetil-)-4-fenil-4',9'-dihidro-3'H-spiro(cikloheksan-1,1'-pirano (3,4,b)indol)-4-amin |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP2600846B1 (sl) |
JP (1) | JP6010534B2 (sl) |
KR (1) | KR101882663B1 (sl) |
CN (1) | CN103079548A (sl) |
AR (1) | AR082561A1 (sl) |
AU (1) | AU2011287952B2 (sl) |
BR (1) | BR112013002696A2 (sl) |
CA (1) | CA2804077C (sl) |
CL (1) | CL2012003583A1 (sl) |
CO (1) | CO6640317A2 (sl) |
DK (1) | DK2600846T3 (sl) |
EC (1) | ECSP13012424A (sl) |
ES (1) | ES2563735T3 (sl) |
HK (1) | HK1183612A1 (sl) |
HR (1) | HRP20151337T1 (sl) |
HU (1) | HUE028436T2 (sl) |
IL (1) | IL223888A (sl) |
MX (1) | MX2013000015A (sl) |
NZ (1) | NZ605841A (sl) |
PE (1) | PE20131106A1 (sl) |
PL (1) | PL2600846T3 (sl) |
PT (1) | PT2600846E (sl) |
RS (1) | RS54659B1 (sl) |
RU (1) | RU2589831C2 (sl) |
SI (1) | SI2600846T1 (sl) |
TW (1) | TWI526445B (sl) |
WO (1) | WO2012016695A2 (sl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112013002734A2 (pt) | 2010-08-04 | 2016-06-07 | Gruenenthal Gmbh | uso de agente farmacologicamente ativo e forma de dosagem farmacêutica |
WO2013087591A1 (en) * | 2011-12-12 | 2013-06-20 | Grünenthal GmbH | Solid forms of (1r,4r)-6'-fluoro-(n,n-dimethyl)-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and sulfuric acid |
EP2797923B1 (en) * | 2011-12-12 | 2016-09-07 | Grünenthal GmbH | Solid forms of (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine hydrochloride |
US9855286B2 (en) * | 2012-05-18 | 2018-01-02 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component |
US9320729B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
US20130310385A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants |
US9345689B2 (en) * | 2012-05-18 | 2016-05-24 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant |
US9320725B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid |
US20130310435A1 (en) * | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol |
US9308196B2 (en) * | 2012-05-18 | 2016-04-12 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam |
US8912226B2 (en) * | 2012-05-18 | 2014-12-16 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR |
US10034958B2 (en) | 2013-06-19 | 2018-07-31 | The Brigham And Women's Hospital, Inc. | Nanocomposite hydrogels |
DK3247352T3 (da) * | 2015-01-23 | 2020-09-07 | Gruenenthal Gmbh | Cebranopadol til behandling af smerter hos individer med forringet lever- og/eller forringet nyrefunktion |
US11083780B2 (en) | 2015-07-20 | 2021-08-10 | The Brigham And Women's Hospital, Inc. | Shear-thinning compositions as an intravascular embolic agent |
BR112018017167A2 (pt) | 2016-02-29 | 2019-01-02 | Gruenenthal Gmbh | titulação de cebranopadol |
CA3178470A1 (en) * | 2020-04-03 | 2021-10-07 | Vertex Pharmaceuticals Incorporated | Modulators of alpha-1 antitrypsin |
WO2024129782A1 (en) | 2022-12-12 | 2024-06-20 | Park Therapeutics, Inc. | Regimens and compositions useful for alleviating pain |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
DE10252667A1 (de) * | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
DE102005005446A1 (de) * | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE102006046745A1 (de) * | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
-
2011
- 2011-08-04 WO PCT/EP2011/003900 patent/WO2012016695A2/en active Application Filing
- 2011-08-04 EP EP11745928.9A patent/EP2600846B1/en active Active
- 2011-08-04 BR BR112013002696A patent/BR112013002696A2/pt not_active IP Right Cessation
- 2011-08-04 RS RS20160105A patent/RS54659B1/en unknown
- 2011-08-04 CA CA2804077A patent/CA2804077C/en not_active Expired - Fee Related
- 2011-08-04 PT PT117459289T patent/PT2600846E/pt unknown
- 2011-08-04 CN CN2011800382208A patent/CN103079548A/zh active Pending
- 2011-08-04 JP JP2013522134A patent/JP6010534B2/ja not_active Expired - Fee Related
- 2011-08-04 KR KR1020137005293A patent/KR101882663B1/ko active IP Right Grant
- 2011-08-04 PE PE2013000193A patent/PE20131106A1/es active IP Right Grant
- 2011-08-04 SI SI201130711T patent/SI2600846T1/sl unknown
- 2011-08-04 AU AU2011287952A patent/AU2011287952B2/en not_active Ceased
- 2011-08-04 AR ARP110102821A patent/AR082561A1/es not_active Application Discontinuation
- 2011-08-04 ES ES11745928.9T patent/ES2563735T3/es active Active
- 2011-08-04 DK DK11745928.9T patent/DK2600846T3/en active
- 2011-08-04 PL PL11745928T patent/PL2600846T3/pl unknown
- 2011-08-04 MX MX2013000015A patent/MX2013000015A/es active IP Right Grant
- 2011-08-04 TW TW100127868A patent/TWI526445B/zh not_active IP Right Cessation
- 2011-08-04 HU HUE11745928A patent/HUE028436T2/hu unknown
- 2011-08-04 RU RU2013109138/15A patent/RU2589831C2/ru not_active IP Right Cessation
- 2011-08-04 NZ NZ605841A patent/NZ605841A/en not_active IP Right Cessation
-
2012
- 2012-12-19 CO CO12230455A patent/CO6640317A2/es not_active Application Discontinuation
- 2012-12-19 CL CL2012003583A patent/CL2012003583A1/es unknown
- 2012-12-25 IL IL223888A patent/IL223888A/en active IP Right Grant
-
2013
- 2013-02-04 EC ECSP13012424 patent/ECSP13012424A/es unknown
- 2013-08-16 HK HK13109593.7A patent/HK1183612A1/xx not_active IP Right Cessation
-
2015
- 2015-12-07 HR HRP20151337TT patent/HRP20151337T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI2600846T1 (sl) | Farmacevtska odmerna oblika, ki obsega 6'-fluoro-(N-metil- ali N,N-dimetil-)-4-fenil-4',9'-dihidro-3'H-spiro(cikloheksan-1,1'-pirano (3,4,b)indol)-4-amin | |
HRP20181856T1 (hr) | Farmaceutski oblik doziranja koji sadrži 6'-fluoro-(n-metil-ili n,n-dimetil-)-4-fenil-4'9'-dihidro-3'h-spiro[ciklohesan-1,1'-pirano[3,4,b]indol]-4-amin za liječenje nociceptivne boli | |
SI2600838T1 (sl) | Farmacevtska odmerna oblika, ki obsega 6'-fluoro-(N-metil- ali N,N-dimetil-)-4-fenil-4',9'-dihidro-3'H-spiro(cikloheksan-1,1'-pirano (3,4,b)indol)-4-amin | |
ZA201006029B (en) | Pharmaceutical dosage form | |
ZA201005015B (en) | Solid pharmaceutical dosage form | |
IL211400A0 (en) | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof | |
IL222919A0 (en) | Alcohol - resistant oral pharmaceutical form | |
ZA200903858B (en) | Pharmaceutical dosage form | |
IL219617A0 (en) | Pharmaceutical solid dosage form | |
SI2852384T1 (sl) | Farmacevtski sestavek, ki obsega (1r,4r)-6'-fluoro-N,N-dimetil-4-fenil- 4',9'-dihidro-3'H-spiro(cikloheksan-1,1'-pirano(3,4,b)indol)-4-amin in antikonvulziv | |
RS56771B1 (sr) | Farmaceutska kompozicija koja sadrži (1r,4r)-6’-fluoro-n,n-dimetil-4-fenil-4’,9’-dihidro-3’h-spiro[cikloheksan-1,1’-pirano-[3,4,b]indol]-4-amin i ibuprofen | |
ZA201300038B (en) | Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl-or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine | |
IL235658A (en) | Pharmaceutical Composition Containing (1r, 4r) - 6 '- Fluoro - n, n - Dimethyl - 4 - Phenyl - 4', 9 '- Dihydro - 3'h - Spiro [Cyclohexane - 1, 1' - Pirano [3, 4 , b] indole] - 4 - amine and gabapentinoid | |
EP2578199A4 (en) | UNIDOSE PACKAGING FOR MEDICAMENTS | |
HUE041960T2 (hu) | 6'-fluor-(N-metil- vagy N,N-dimetil-)-4-fenil-4',9'-dihidro-3'H spiro[ciklohexán-1,1'-pirano[3,4,b]indol]-4-amint tartalmazó gyógyszerészeti dózisforma nociceptív fájdalom kezelésére | |
ZA201201424B (en) | Pharmaceutical dosage form | |
GB201018760D0 (en) | An oral dosage form |